Related references
Note: Only part of the references are listed.Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells
Noura N. Alraouji et al.
MOLECULAR CARCINOGENESIS (2021)
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma
Yujia Zheng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients
Kirstin Harling et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Yueh-Shan Weng et al.
MOLECULAR CANCER (2019)
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
Dan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
Y. Qiao et al.
ONCOGENE (2018)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
The role of CD133 in cancer: a concise review
Paige M. Glumac et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Song Xue et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway
Jian Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma
Wei Zhang et al.
MOLECULAR NEUROBIOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo et al.
BRITISH JOURNAL OF CANCER (2016)
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Dongjun Peng et al.
CANCER RESEARCH (2016)
B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients
Yu Yao et al.
CLINICAL CANCER RESEARCH (2016)
Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages (Publication with Expression of Concern. See vol. 151, 2022)
Lifeng Li et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
Pasquale Sansone et al.
NATURE COMMUNICATIONS (2016)
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Elena Codrici et al.
STEM CELLS INTERNATIONAL (2016)
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Brandon D. Liebelt et al.
STEM CELLS INTERNATIONAL (2016)
Increased proportion of FoxP3+regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
Elias J. Sayour et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer
Dongli Yue et al.
EXPERIMENTAL CELL RESEARCH (2015)
The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression
Alfred P. See et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
Ilona Kryczek et al.
IMMUNITY (2014)
The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Alina Filatova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
Braden C. McFarland et al.
PLOS ONE (2013)
Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway
Xian-zong Ye et al.
JOURNAL OF IMMUNOLOGY (2012)
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines
Dagmar Beier et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
Li Lin et al.
CANCER RESEARCH (2011)
Foxp3(+)IL-17(+) T cells promote development of cancer-initiating cells in colorectal cancer
Shaobo Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
Justin D. Lathia et al.
PLOS ONE (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
TGFβ1 Induces IL-6 and Inhibits IL-8 Release in Human Bronchial Epithelial Cells: The Role of Smad2/3
Qi Ge et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
Silvia Penuelas et al.
CANCER CELL (2009)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Interleukin-6 gene amplification and shortened survival in glioblastoma patients
A. Tchirkov et al.
BRITISH JOURNAL OF CANCER (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Opposite effect of corticosteroids and long-acting beta 2-agonits on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts
Stephanie Goulet et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme
CY Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2005)
Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways
JI Park et al.
ONCOGENE (2003)
Requirement of hydrogen peroxide generation in TGF-β1 signal transduction in human lung fibroblast cells:: Involvement of hydrogen peroxide and Ca2+ in TGF-β1-induced IL-6 expression
E Junn et al.
JOURNAL OF IMMUNOLOGY (2000)